| 股號 / 名稱 | 營業現金流 | 自由現金流 | 淨現金流 |
| NVO 諾和諾德 | 273,733,989,685.39 | 210,253,332,391.55 | 115,818,354,120.59 |
| AMGN 美國安進 | 129,848,690,019.06 | 113,203,917,910.17 | 63,302,047,533.03 |
| MRK 默克藥廠 | 174,234,748,976.1 | 145,260,516,045.81 | 48,441,802,648.29 |
| 6620 漢達 | 264,222,000 | 261,998,000 | 470,802,000 |
| 1795 美時 | 701,365,000 | 603,443,000 | 150,870,000 |
| 4166 友霖 | 52,806,000 | 22,052,000 | -81,478,000 |
| 6589 台康生技 | -68,004,000 | -242,795,000 | -398,591,000 |
| TEVA Teva Pharmaceutical Industries Limited | 13,367,731,206.36 | 9,960,906,505.71 | -2,790,351,659.58 |
| BMY 施貴寶 | 110,089,106,755.29 | 100,193,092,148.64 | -27,935,962,545.33 |
| GILD 吉利德科學 | 115,929,377,670.69 | 111,386,944,736.49 | -144,384,475,408.5 |
載入數據中...
和藥價與專利壓力相關的產業概念股
藥價與專利壓力概念股相關指標排名
藥價與專利壓力每月營收
藥價與專利壓力每股盈餘
藥價與專利壓力每股淨值
藥價與專利壓力損益表
藥價與專利壓力總資產
藥價與專利壓力負債和股東權益
藥價與專利壓力現金流量表
藥價與專利壓力利潤比率
藥價與專利壓力營業費用率拆解
藥價與專利壓力杜邦分析
藥價與專利壓力ROE / ROA
藥價與專利壓力經營週轉能力
藥價與專利壓力營運週轉天數
藥價與專利壓力現金股利發放率
藥價與專利壓力財務結構比率
藥價與專利壓力流速動比率
藥價與專利壓力利息保障倍數
藥價與專利壓力現金流量分析
藥價與專利壓力營業現金流對淨利比
藥價與專利壓力盈餘再投資比率
藥價與專利壓力月營收成長率
藥價與專利壓力營收成長率
藥價與專利壓力毛利成長率
藥價與專利壓力營業利益成長率
藥價與專利壓力稅後淨利成長率
藥價與專利壓力每股盈餘成長率
藥價與專利壓力本益比評價
藥價與專利壓力股價淨值比評價
藥價與專利壓力現金股利殖利率
藥價與專利壓力平均現金股息殖利率
藥價與專利壓力董監持股比例
藥價與專利壓力董監持股質押比例